glp-1 and alcoholism IUPHAR review – Glucagon-like peptide-1 (GLP-1) substance use disorders: An emerging pharmacotherapeutic target glp 1 alcohol consumption Could

Ingredients: Water (Aqua), Isopropyl Palmitate, Caprylic/Capric Triglyceride, Stearic Acid, C15-19 Alkane, Butyrospermum Parkii (Shea) Butter, Cetyl Alcohol, Glyceryl Stearate SE, Glycerin, Canola Oil, Cetearyl Olivate, Coco-Caprylate/Caprate, Mangifera Indica (Mango) Seed Butter, Sorbitan Olivate, 1,2-Hexanediol, Caprylyl Glycol, Malus Domestica Fruit Extract, Hydroxyacetophenone, Zingiber Officinale (Ginger) Extract, Caprae Lac (Goat Milk), Citrus Aurantium Bergamia (Bergamot) Fruit Oil, Dimethicone, Xanthan Gum, Carbomer, Squalane, Hydrolyzed Collagen, Lactobionic Acid, Trichilia Emetica Seed Butter, Lactic Acid, Tocopherol, Propanediol, Ethylene/Propylene/Styrene Copolymer, Butylene Glycol, Butylene/Ethylene/Styrene Copolymer, Polyglutamic Acid, Bifida Ferment Lysate, Lactose, Milk Protein, Pentaerythrityl Tetra-di-t-butyl Hydroxyhydrocinnamate, Nicotiana Benthamiana Hexapeptide-40 sh-Polypeptide-76

Form / Delivery Method: Sublingual drops

If drug/chemical induced: - Code first T36T50 (drug code) with 5th/6th characters for poisoning/adverse effect

For many patients, taking it at night can help minimize side effects